Cynapsus
is a central nervous system pharmaceutical company that develops sublingual film product to treat the motor symptoms of Parkinson's disease... Read moreCynapsus
is a central nervous system pharmaceutical company that develops sublingual film product to treat the motor symptoms of Parkinson's disease... Read more
News
Dec 20, 2016
Financial Market News
Cynapsus: Stevens Capital Management LP Buys Shares of 51,590 Cynapsus Therapeutics Inc. (CYNA)
Dec 16, 2016
The Vista Voice
Cynapsus: Longfellow Investment Management Co. LLC Buys Shares of 175,000 Cynapsus Therapeutics Inc. (CYNA)
Oct 22, 2016
4-traders
Cynapsus: Sumitomo Chemical : Sunovion Pharmaceuticals Completes Acquisition of Cynapsus Therapeutics
Oct 14, 2016
4-traders
Cynapsus: Sumitomo Chemical : Cynapsus Therapeutics Receives Shareholder Approval for Sunovion Pharma the Plan of Arrangement
Oct 11, 2016
4-traders
Cynapsus: CYNAPSUS THERAPEUTICS INC. : Unregistered Sale of Equity Securities (form 8-K)
Sep 29, 2016
ForexTV
Cynapsus: ISS Recommends Cynapsus Therapeutics Securityholders Vote for the Plan of Arrangement
Sep 24, 2016
Zolmax News
Cynapsus: Analysts Expect Cynapsus Therapeutics Inc. (NASDAQ:CYNA) to Announce ($0.75) EPS
Sep 20, 2016
American Banking and Market News
Cynapsus: Cynapsus Therapeutics Inc. (CYNA) Sets New 1-Year High at $40.25
Sep 19, 2016
American Banking and Market News
Cynapsus: Cynapsus Therapeutics Inc. (NASDAQ:CYNA) Receives Average Rating of "Buy" from Brokerages
Sep 14, 2016
American Banking and Market News
Cynapsus: Cynapsus Therapeutics Inc. (CYNA) Hits New 52-Week High at $40.13
Cynapsus Competitors
1
2
3
4
5
6
7
8
9
10